Parkinsonism induced by solvent abuse - PubMed (original) (raw)
Case Reports
Parkinsonism induced by solvent abuse
R J Uitti et al. Ann Neurol. 1994 May.
Abstract
We report the first description of a patient with parkinsonism induced by solvent abuse. Our patient developed parkinsonism acutely, following heavy abuse of lacquer thinner. Her clinical deficits were indistinguishable from idiopathic parkinsonism (Parkinson's disease) and she responded to levodopa. Parkinsonism has persisted for more than 3 months. Brain computed tomography was normal. Positron emission tomographic studies showed normal fluorodopa uptake and reduced raclopride binding, indicating an unusual disturbance of striatal dopaminergic function. This patient suggests that organic solvents may cause parkinsonism in susceptible individuals.
Similar articles
- Dopa-responsive parkinsonism with normal 6[18F]-fluorodopa positron emission tomography scans.
Lang AE, Garnett ES. Lang AE, et al. Ann Neurol. 1990 Oct;28(4):592-3. doi: 10.1002/ana.410280427. Ann Neurol. 1990. PMID: 2252376 No abstract available. - Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure.
Hageman G, van der Hoek J, van Hout M, van der Laan G, Steur EJ, de Bruin W, Herholz K. Hageman G, et al. J Neurol. 1999 Mar;246(3):198-206. doi: 10.1007/s004150050334. J Neurol. 1999. PMID: 10323318 - Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Widner H, Tetrud J, Rehncrona S, Snow B, Brundin P, Gustavii B, Björklund A, Lindvall O, Langston JW. Widner H, et al. N Engl J Med. 1992 Nov 26;327(22):1556-63. doi: 10.1056/NEJM199211263272203. N Engl J Med. 1992. PMID: 1435882 Clinical Trial. - Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2).
Furtado S, Payami H, Lockhart PJ, Hanson M, Nutt JG, Singleton AA, Singleton A, Bower J, Utti RJ, Bird TD, de la Fuente-Fernandez R, Tsuboi Y, Klimek ML, Suchowersky O, Hardy J, Calne DB, Wszolek ZK, Farrer M, Gwinn-Hardy K, Stoessl AJ. Furtado S, et al. Mov Disord. 2004 Jun;19(6):622-9. doi: 10.1002/mds.20074. Mov Disord. 2004. PMID: 15197699 Review.
Cited by
- Solvent exposed occupations and risk of Parkinson disease in Finland.
Nielsen SS, Warden MN, Sallmén M, Sainio M, Uuksulainen S, Checkoway H, Hublin C, Racette BA. Nielsen SS, et al. Clin Park Relat Disord. 2021 Apr 20;4:100092. doi: 10.1016/j.prdoa.2021.100092. eCollection 2021. Clin Park Relat Disord. 2021. PMID: 34316670 Free PMC article. - Biophysical Characterization of α-Synuclein and Rotenone Interaction.
Silva BA, Einarsdóttir O, Fink AL, Uversky VN. Silva BA, et al. Biomolecules. 2013 Sep 24;3(3):703-32. doi: 10.3390/biom3030703. Biomolecules. 2013. PMID: 24970188 Free PMC article. - Targeting the chameleon: a focused look at α-synuclein and its roles in neurodegeneration.
Silva BA, Breydo L, Uversky VN. Silva BA, et al. Mol Neurobiol. 2013 Apr;47(2):446-59. doi: 10.1007/s12035-012-8334-1. Epub 2012 Sep 1. Mol Neurobiol. 2013. PMID: 22940885 Review. No abstract available. - Solvent exposures and Parkinson disease risk in twins.
Goldman SM, Quinlan PJ, Ross GW, Marras C, Meng C, Bhudhikanok GS, Comyns K, Korell M, Chade AR, Kasten M, Priestley B, Chou KL, Fernandez HH, Cambi F, Langston JW, Tanner CM. Goldman SM, et al. Ann Neurol. 2012 Jun;71(6):776-84. doi: 10.1002/ana.22629. Epub 2011 Nov 14. Ann Neurol. 2012. PMID: 22083847 Free PMC article. - The role of environmental exposures in neurodegeneration and neurodegenerative diseases.
Cannon JR, Greenamyre JT. Cannon JR, et al. Toxicol Sci. 2011 Dec;124(2):225-50. doi: 10.1093/toxsci/kfr239. Epub 2011 Sep 13. Toxicol Sci. 2011. PMID: 21914720 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical